Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266,434,249
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
124,526,898
-
Shares change
-
-3,210,622
-
Total reported value, excl. options
-
$508,113,977
-
Value change
-
-$12,215,240
-
Put/Call ratio
-
852%
-
Number of buys
-
69
-
Number of sells
-
-56
-
Price
-
$4.08
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q4 2023
158 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124,526,898 shares
of 266,434,249 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (25,001,856 shares), FMR LLC (15,751,291 shares), CANADA PENSION PLAN INVESTMENT BOARD (10,175,000 shares), BAILLIE GIFFORD & CO (10,150,017 shares), VANGUARD GROUP INC (9,797,084 shares), BlackRock Inc. (8,469,222 shares), STATE STREET CORP (5,908,687 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,594,025 shares), Crestline Management, LP (3,365,624 shares), and Alphabet Inc. (2,812,500 shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.